Octagon Capital Advisors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839435

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2024 · 44 positions · Total reported value $482.20M · Top-10 concentration 59.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.5% · 2 new · 14 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.3% · vs SPY -25.4% · Prev Value $1.11B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -9.9% · vs SPY -12.0% · Latest Value $750.61M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Octagon Capital Advisors LP disclosed 44 equity positions with a combined reported value of $482.20M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.4% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were DNTH ($45.20M), GPCR ($44.77M), DYN ($41.67M). By sector, the heaviest allocations are Health Care 70.5%, Industrials 2.0%. Versus the prior quarter, allocation shifted toward Health Care (+6.2pp) and away from Industrials (-1.4pp), Other (-4.8pp).

Versus the prior quarter, Octagon Capital Advisors LP opened 2 new positions, trimmed 14 and fully exited 3, a turnover rate of 65.5% of positions. The portfolio's overlap with the prior quarter was 72% of names.

The largest new positions opened in Q2 2024 were RGLS ($7.61M), ELEV ($2.02M).

Of the 3 positions fully exited versus the prior quarter, the largest were ALPN ($49.21M), CYTK ($13.60M), NAMS ($9.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • RGLS REGULUS THERAPEUTICS INC · $7.61M
  • ELEV ELEVATION ONCOLOGY INC · $2.02M

Fully Exited (vs previous quarter)

  • ALPN ALPINE IMMUNE SCIENCES INC · prev qtr: $49.21M
  • CYTK CYTOKINETICS INC · prev qtr: $13.60M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · prev qtr: $9.65M
  • GLYC GLYCOMIMETICS INC · prev qtr: $9.00M
  • IMVT IMMUNOVANT INC · prev qtr: $8.83M
  • ARWR ARROWHEAD PHARMACEUTICALS IN · prev qtr: $7.15M
  • VINC VINCERX PHARMA INC · prev qtr: $5.06M
  • PHAT PHATHOM PHARMACEUTICALS INC · prev qtr: $4.83M

Insider Transactions (Form 4)

Latest Octagon Capital Advisors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Octagon Capital Advisors LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 26 US equity positions with a combined value of $750.61M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118554 (status: Approved), registered 2020-04-27
  • Regulatory AUM (Form ADV): $1.18B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 1 hedge funds
  • Website: octagoninvestments.com

Portfolio Structure

  • 26 positions · $750.61M reported value (Q3 2026)
  • Top 10 holdings = 82.5% of reported value
  • Largest position: DNTH (DIANTHUS THERAPEUTICS INC) at 19.8%
  • Average position size: $28.87M

Sector Tilt

  • Health Care 99.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 1 added, 14 reduced, 3 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 70.5%
Other 27.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.75M $45.20M 9.37%
9.37%
Add
2 1.14M $44.77M 9.29%
9.29%
Add
3 1.18M $41.67M 8.64%
8.64%
Reduce
4 1.80M $33.45M 6.94%
6.94%
Reduce
5 1.90M $27.40M 5.68%
5.68%
Reduce
6 488.00K $22.08M 4.58%
4.58%
Add
7 2.35M $21.18M 4.39%
4.39%
Add
8 690.00K $17.48M 3.62%
3.62%
Hold
9 250.00K $16.75M 3.47%
3.47%
Reduce
10 2.42M $16.59M 3.44%
3.44%
Hold
11 1.58M $15.76M 3.27%
3.27%
Reduce
12 2.15M $15.52M 3.22%
3.22%
Hold
13 350.00K $13.43M 2.78%
2.78%
Add
14 260.00K $10.75M 2.23%
2.23%
Hold
15 4.57M $10.24M 2.12%
2.12%
Add
16 1.09M $9.51M 1.97%
1.97%
Hold
17 1.36M $9.29M 1.93%
1.93%
Add
18 9.19M $8.28M 1.72%
1.72%
Hold
19 620.00K $8.07M 1.67%
1.67%
Hold
20 2.58M $7.99M 1.66%
1.66%
Reduce
21 4.26M $7.61M 1.58%
1.58%
New
22 9.80M $7.09M 1.47%
1.47%
Add
23 600.00K $7.02M 1.46%
1.46%
Add
24 3.22M $6.92M 1.44%
1.44%
Add
25 283.37K $6.65M 1.38%
1.38%
Reduce
26 287.50K $6.53M 1.35%
1.35%
Reduce
27 376.12K $6.00M 1.25%
1.25%
Hold
28 2.39M $5.52M 1.15%
1.15%
Add
29 18.60M $5.04M 1.05%
1.05%
Hold
30 1.33M $3.40M 0.70%
0.70%
Add
31 2.25M $3.40M 0.70%
0.70%
Hold
32 176.00K $3.34M 0.69%
0.69%
Reduce
33 250.00K $2.56M 0.53%
0.53%
Hold
34 736.00K $2.15M 0.45%
0.45%
Hold
35 747.00K $2.02M 0.42%
0.42%
New
36 992.00K $1.99M 0.41%
0.41%
Reduce
37 400.00K $1.96M 0.41%
0.41%
Reduce
38 520.80K $1.71M 0.35%
0.35%
Hold
39 240.00K $1.42M 0.29%
0.29%
Hold
40 431.60K $1.26M 0.26%
0.26%
Reduce
41 767.80K $929.04K 0.19%
0.19%
Hold
42 292.00K $890.60K 0.18%
0.18%
Hold
43 465.44K $772.63K 0.16%
0.16%
Add
44 176.00K $612.48K 0.13%
0.13%
Hold

FAQ

What did Octagon Capital Advisors LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Octagon Capital Advisors LP reported 44 equity positions worth $482.20M in aggregate; its largest disclosed positions were DNTH ($45.20M), GPCR ($44.77M), DYN ($41.67M).

How large is Octagon Capital Advisors LP's portfolio?

Octagon Capital Advisors LP reported $482.20M of long equity holdings across 44 positions as of 2024-Q2. Top-10 holdings account for 59.4% of reported value.

What is Octagon Capital Advisors LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/octagon-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →